Smartwatch aims to replace finger pricks and cuffs

NCT ID NCT05904769

Terminated Diagnosis Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Mayo Clinic study tested a special smartwatch that uses light sensors to measure blood glucose, blood pressure, and heart signals. The goal was to see if the watch could give accurate readings compared to standard methods like finger-stick tests and blood pressure cuffs. The study included 87 diabetic patients who were already having regular blood sugar checks. However, the study was terminated early, so the final results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LIFELEAF Smartwatch (wearable device using light sensors)
What this could lead to: If successful, this could lead to a convenient, non-invasive way for people with diabetes to check blood sugar and blood pressure using just a smartwatch.
What could go wrong: This was a small, early-stage study that was terminated, so results may be limited. The technology may not be as accurate as standard blood tests or cuffs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES

Contacts and locations

Locations

Mayo Clinic Minnesota

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.